menu
    • menu

    Company profile for Inspirna

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Inspirna is developing first-in-class drugs that target key pathways in cancer progression. Using a discovery platform developed by Inspirna's founding scientists at Rockefeller University, we have discovered several novel cancer targets that drive tumor growth and cancer progression. These targets regulate key components of the tumor micro-environment including immune cells and cancer metabolism pathways. Our discovery platf...
    Inspirna is developing first-in-class drugs that target key pathways in cancer progression. Using a discovery platform developed by Inspirna's founding scientists at Rockefeller University, we have discovered several novel cancer targets that drive tumor growth and cancer progression. These targets regulate key components of the tumor micro-environment including immune cells and cancer metabolism pathways. Our discovery platform - which can be applied to virtually any tumor type - has yielded novel therapeutic targets for several high-unmet need cancer types to date.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InspirnaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    310 E 67th St, Suite 1-12‎ New York, NY
    Telephone
    Telephone
    (646) 856-9261
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://inspirna.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/inspirna/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cancer biotech Inspirna winding down
    Cancer biotech Inspirna winding down

    01 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/cancer-biotech-inspirna-winding-down-its-odyssey-microrna-comes-end

    FIERCE BIOTECH
    01 Apr 2025
    Share Share
    Inspirna Appoints Benhadji As CMO, Wasserman Retires
    Inspirna Appoints Benhadji As CMO, Wasserman Retires

    21 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240521372017/en

    BUSINESSWIRE
    21 May 2024
    Share Share
    Inspirna to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    Inspirna to Present at the 42nd Annual J.P. Morgan Healthcare Conference

    04 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240104265968/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Inspirna Partners with Merck to Accelerate Global Development of Ompenaclid
    Inspirna Partners with Merck to Accelerate Global Development of Ompenaclid

    04 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240104830287/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Inspirna Announces Clinical Data from Phase 1b/2 Study of Ompenaclid
    Inspirna Announces Clinical Data from Phase 1b/2 Study of Ompenaclid

    23 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231023708620/en

    BUSINESSWIRE
    23 Oct 2023
    Share Share
    Inspirna to Present Clinical Data from Phase 1b/2 Study of Ompenaclid
    Inspirna to Present Clinical Data from Phase 1b/2 Study of Ompenaclid

    16 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231016553717/en

    BUSINESSWIRE
    16 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search